Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.8.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Nov. 30, 2017
Aug. 31, 2017
Current    
Cash $ 2,209,703 $ 2,533,337
Accounts and other receivables 71,923 45,293
Inventory 77,436 67,174
Prepaid expenses and deposit 58,140 149,691
Total Current Assets 2,417,202 2,795,495
Patents 78,321 62,827
Equipment 1,702 1,856
Total Noncurrent Assets 80,023 64,683
TOTAL ASSETS 2,497,225 2,860,178
Current    
Accounts payable and accrued liabilities 59,854 32,574
Unearned revenue 10,833 17,083
Due to related parties 25,018 42,690
Total Current Liabilities 95,705 92,347
TOTAL LIABILITIES 95,705 92,347
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 69,435,198 common shares at November 30, 2017 and 67,975,761 common shares at August 31, 2017 69,435 67,976
Additional paid-in capital 16,080,737 16,108,270
Deficit (13,748,652) (13,169,939)
Equity attributable to shareholders of the Company 2,401,520 3,006,307
Non-Controlling Interest 0 (238,476)
Total Stockholders' Equity 2,401,520 2,767,831
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,497,225 $ 2,860,178